These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-003644-59 A two months study of the utility of Elidel cream 1% (pimecrolimus) in the long term management of atopic hand eczema. not-yet-due
No trial status on register 2005-004151-35 Pharmacokinetics of oral cefuroxime-axetil compared to intravenous cefuroxime in term neonates and possible adjustment of the oral therapy bad-data
Not reported 2005-004677-20 Randomised Phase II/III Study on Sectional Single Agent Gemcitabine and Docetaxel Versus Carboplatine / Gemcitabine Doublet Therapy, both combined Cetuximab in the Treatment of Advanced NSCLC (Stage I... 2013-09-25 due-trials
Reported results 2005-005471-15 Real-time contrast-enhanced sonography of renal transplant recipients accurately predicts chronic allograft nephropathy 2007-12-31 due-trials
Ongoing 2006-001935-23 Real-time contrast-enhanced sonography of renal transplant recipients accurately predicts vascular allograft nephropathy not-yet-due
Ongoing 2006-004349-41 Supportive Schmerztherapie-Studie - Einfluss von Physostigmin auf die patientenkontrollierte Analgesie (PCA) in der postoperativen Phase bei Intensivpatienten not-yet-due
Not reported 2006-004977-91 Inhalative Sedierung mit Sevofluran im Vergleich zu Propofol bei beatmeten, postoperativen Intensivpatienten – Einfluss auf Extubationszeiten und Aufwachverhalten, Nieren- und Leberfunktion, Hämodynam... 2008-03-01 due-trials
Not reported 2007-000624-40 PHASE II STUDY TO EVALUATE GLIVEC (IMATINIB MESYLATE) TO INDUCE PROGRESSION ARREST IN AGGRESSIVE FIBROMATOSIS / DESMOID TUMORS NOT AMENABLE TO SURGICAL RESECTION WITH R0 INTENT OR ACCOMPANIED BY UNACC... 2015-09-30 due-trials
Completed, but no date, and reported results Terminated 2007-004603-35 Radiotherapy (IMRT), Erbitux And Chemotherapy For Unresectable Carcinomas Of Head and Neck. REACH-Study bad-data
Reported results Terminated 2007-006014-41 Determination of Diagnostic Accuracy and Added Value of Vasovist®-Enhanced Peripheral MRA in Comparison to Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients with Peripheral Artery ... 2010-11-25 due-trials
Ongoing 2007-007792-17 Vasovist®-enhanced MRI in Preoperative Lymph Node Staging of Lung Cancer: Comparison with 18F FDG PET/CT not-yet-due
Reported results Terminated 2008-000121-19 A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Resected Pancreatic Adenocarcinoma Treated with Interferon Alpha-2b and 5-FU Alone or in Combination with Either Ext... 2010-05-14 due-trials
Not reported Terminated 2008-001787-36 Verbessert die perioperative Applikation von Esketamin in subanästhetischer Dosierung die postoperative Analgesie? 2011-02-28 due-trials
Ongoing 2009-009426-81 Contrast-enhanced Imaging of the Abdomen: Gadovist® vs. Dotarem® – Intraindividual comparison of 0.1mmol/kg bw gadoterate meglumine with 0.1mmol/kg bw gadobutrol for dynamic abdominal imaging in patie... not-yet-due
Not reported 2009-011095-30 Intra-individual comparison of Gd-EOB-DTPA disodium (Primovist) and Gadobutrol (Gadovist) in patients with suspicion of hepatocellular carcinoma 2013-08-08 due-trials
Completed, but no date, and reported results 2009-016489-10 Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced ... bad-data
Reported results 2010-019748-38 Hautveränderungen bei Patienten mit Kopf- und Halstumor unter kombinierter RadioImmuno-(chemo)-therapie mit Erbitux® 2015-11-04 due-trials
Listed as ongoing, but also has a completion date 2011-000440-22 MULTICENTER TRIAL ESTIMATING THE PERSISTANCE OF MOLECULAR REMISSION IN CHRONIC MYELOID LEUKAEMIA AFTER STOPPING TKI 2017-11-20 bad-data
Not reported Terminated 2011-003745-18 A PHASE II WINDOW-OF-OPPORTUNITY STUDY OF PREOPERATIVE THERAPY WITH PAZOPANIB (VOTRIENT®) IN HIGH-RISK SOFT TISSUE SARCOMA 2016-12-31 due-trials
Listed as ongoing, but also has a completion date 2012-005846-39 Phase II, multicenter, open-label, single-arm trial in advanced and relapsed Angiosarcomas, to evaluate the efficacy of pazopanib (Votrient) in combination with standard of care treatment paclitaxel (... 2019-12-31 bad-data
Not reported 2014-000924-11 Phase IIA Study on therapy with the NF-kB inhibiting and apoptosis inducing drug dimethylfumarate (DMF) in Patients with Cutaneous T cell lymphoma. 2021-10-20 due-trials
Reported results Terminated 2014-004597-42 LGX818 in combination with MEK162 in refractory or relapsed multiple myeloma patients with BRAFV600E or BRAFV600K mutation 2023-03-29 due-trials
Reported results 2015-001309-14 Comparison of the efficacy of using a human acellular dermis (Epiflex®) against the surgical standard procedure for closing an open abdomen with respect to avoiding ventral hernia. A monocenter, part... 2019-05-02 due-trials
Ongoing 2015-004998-33 Multicenter prospective trial after first or second unsuccessful treatment discontinuation in chronic myeloid leukemia estimating the efficacy of nilotinib in inducing the persistence of molecular rem... not-yet-due
Other 2017-000514-35 Prospective Randomised Open-label Trial to Evaluate risk faCTor management in patients with Unruptured intracranial aneurysms (PROTECT-U) Aivovaltimoaneurysmien vuodon ehkäisy lääkehoidon ja yksi... not-yet-due
Other 2018-001356-35 ACO/ARO/AIO-18.2 Preoperative FOLFOX versus postoperative risk-adapted chemotherapy in patients with locally advanced rectal cancer and low risk for local failure: A randomized phase III trial of the... not-yet-due
Other 2018-001728-20 - RACE - Neoadjuvant Radiochemotherapy versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) A randomized phase III join... not-yet-due
Other 2018-004564-59 WITH PONATINIB ON THE TRACK FOR TREATMENT-FREE-REMISSION IN CHRONIC MYELOID LEUKEMIA not-yet-due
Completed, report not yet due Terminated 2020-001397-30 APOS study- Antibiotic Prophylaxis for preventing infectious complications in Orthognathic Surgery Antibiotische Prophylaxe zur Vorbeugung von Infektionen nach Orthognather Umstellungsosteotomie 2024-05-21 not-yet-due
Completed, report not yet due 2021-004789-36 Randomized, controlled trial of the use of intranasal midazolam for the treatment of terminal agitation in palliative care patients Randomisierte, kontrollierte Studie zur Anwendung von intranasale... 2024-07-31 not-yet-due